Biosilimars Obama Unfolds New Opportunities

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Cholestyramine South America Report

Cholestyramine South America Report

  • $ 2 969
  • Industry report
  • by PureData
  • February 2015
  • 1972 pages

CHOLESTYRAMINE SOUTH AMERICA REPORT The Cholestyramine South America Report gives Market Consumption / Products / Services for 13 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered include: Argentina, Bolivia, Brazil, ...

Industries: Drug and Medication | Countries: South America

Cancer Drug News 09 FEBRUARY 2015

Cancer Drug News 09 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 24 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises Industry Trend Analysis - Pfizer's Approval In BC Set To Give Positive Stroke To Company's Declining Revenues Industry Brief - Bio-Path Initiates Phase II Study Of Liposomal Grb In AML Industry Brief - FDA Approves Imbruvica ...

Industries: Drug and Medication | Countries: Germany, United States, South America

CNS Drug News 02 FEBRUARY 2015

CNS Drug News 02 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - Branded Antidepressants Market Has High Potential Despite Current Contraction Industry Brief - AgeneBio Receives Grant For New Approach To Delaying Onset Of Alzheimer's Dementia Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues Industry Brief ...

Industries: Drug and Medication | Countries: United States, Russian Federation, World, South America, Europe

South America: Ginger - Market Report. Analysis and Forecast to 2020

South America: Ginger - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • January 2015

The report provides an in-depth analysis of the South American Market of Ginger. It presents the latest data of the market value, consumption, domestic production, exports and imports, price dynamics and food balance. The report shows the sales data, allowing you to identify the key drivers and restraints. ...

Industries: Drug and Medication | Countries: South America

Instituto Rosenbusch S.A. (Symbol:ROSE) SWOT Analysis, Strategy, Revenues and Profits

Instituto Rosenbusch S.A. (Symbol:ROSE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Instituto Rosenbusch S.A. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Argentina, South America, Uruguay, Paraguay, Brazil

World Intravenous (IV) Iron Drugs Industry

World Intravenous (IV) Iron Drugs Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • January 2015
  • 135 pages

This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. ...

Industries: Drug and Medication | Countries: World, United States, Europe, Japan, Germany, Canada, China, France, Switzerland, Spain, Russian Federation, Italy, India, Brazil, North America, United Kingdom, South America

MarketVIEW: Herpes Zoster (adult) vaccines

MarketVIEW: Herpes Zoster (adult) vaccines

  • $ 4 995
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • October 2014

Varicella-zoster virus is a ubiquitous human alphaherpesvirus, which after infection in childhood causes a relatively mild self-limiting illness. However, if the virus becomes reactivated later on in life it can cause a painful rash (shingles), often leading to postherpetic neuralgia (PHN). PHN has a ...

Industries: Drug and Medication | Countries: United Kingdom, Argentina, Brazil, Mexico, Canada, Spain, Italy, France, Germany, Europe, World, United States, South America, North America

MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 85 pages

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible for around 40% of the total where 5 main serogroups ACWY and B are responsible for the majority ...

Industries: Drug and Medication | Countries: World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America

Dermatological Drugs Market Forecast 2014-2024

Dermatological Drugs Market Forecast 2014-2024

  • $ 2 788
  • Industry report
  • by Visiongain
  • April 2014
  • 272 pages

Future Prospects for Leading Companies Report Details Dermatological drugs - new study showing you trends, R&D progress, and predicted revenues Where's the dermatological drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and ...

Industries: Drug and Medication | Countries: United States, World, Japan, China, Brazil, India, Germany, Mexico, Spain, Italy, France, Asia, North America, Europe, South America, United Kingdom, Russian Federation

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • September 2013
  • 44 pages

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these ...

Industries: Drug and Medication | Countries: Australia, Brazil, World, United States, Spain, Italy, France, Germany, Japan, United Kingdom, China, Europe, Oceania, South America

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.